16/10/2026
Can GLP-1 drugs developed for diabetes protect brain cells in Parkinson's disease? 🧠 Early lab and clinical data show intriguing signs but big questions remain. https://www.news-medical.net/health/Can-GLP-1-Drugs-Treat-Parkinsone28099s-Disease-What-Research-Shows.aspx
GLP-1 receptor agonists affect metabolic, inflammatory, and neuronal survival pathways implicated in Parkinson’s disease, with neuroprotective effects demonstrated in experimental models. Clinical trials have produced mixed findings, leaving disease-modifying benefits unproven and highlighting con...